KCG
WST icon

Knight Capital Group’s West Pharmaceutical WST Stock Holding History

Knight Capital Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$359K Buy
+10,218
New +$336K 0.01% 2045

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Knight Capital Group's WST Position: Q2 2013 in Review

Knight Capital Group opened a new position in West Pharmaceutical (WST) in Q2 2013: 10,218 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #2045 among its holdings.

197 funds tracked by Wall St. Rank hold WST as of Q2 2013.

  • Knight Capital Group held 10,218 shares of West Pharmaceutical worth $359K as of Q2 2013.
  • West Pharmaceutical was a new Knight Capital Group position in Q2 2013.
  • West Pharmaceutical made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2045 holding.
  • 197 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.